Concordance between Two Phenotypic Assays and Ultradeep Pyrosequencing for Determining HIV-1 Tropism

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Full description

Saved in:
Bibliographic Details
Published inAntimicrobial Agents and Chemotherapy Vol. 55; no. 6; pp. 2831 - 2836
Main Authors SALIOU, Adrien, DELOBEL, Pierre, DUBOIS, Martine, NICOT, Florence, RAYMOND, Stéphanie, CALVEZ, Vincent, MASQUELIER, Bernard, IZOPET, Jacques
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.06.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
AbstractList There have been few studies on the concordance between phenotypic assays for predicting human immunodeficiency virus type 1 (HIV-1) coreceptor usage. The sensitivity of ultradeep pyrosequencing combined with genotyping tools is similar to that of phenotypic assays for detecting minor CXCR4-using variants. We evaluated the agreement between two phenotypic assays, the Toulouse tropism test (TTT) and the Trofile assay, and ultradeep pyrosequencing for determining the tropism of HIV-1 quasispecies. The concordance between the TTT and Trofile assays was assessed for 181 samples successfully phenotyped by both assays. The TTT was 86% concordant with the standard Trofile assay and 91.7% with its enhanced-sensitivity version. The concordance between phenotypic characterization of HIV-1 tropism and ultradeep pyrosequencing genotypic prediction was further studied in selected samples. The HIV-1 tropism inferred from ultradeep pyrosequencing of 11 samples phenotyped as X4 and dualtropic and 12 phenotyped as R5-tropic agreed closely with the results of phenotyping. However, ultradeep pyrosequencing detected minor CXCR4-using variants in 3 of 12 samples phenotyped as R5-tropic. Ultradeep pyrosequencing also detected minor CXCR4-using variants that had been missed by direct sequencing in 6 of 9 samples phenotyped as X4-tropic but genotyped as R5-tropic by direct sequencing. Ultradeep pyrosequencing was 87% concordant with the Trofile and TTT phenotypic assays and was in the same range of sensitivity (0.4%) than these two phenotypic assays (0.3 to 0.5%) for detecting minor CXCR4-using variants. Ultradeep pyrosequencing provides a new way to improve the performance of genotypic prediction of HIV-1 tropism to match that of the phenotypic assays.
ABSTRACT There have been few studies on the concordance between phenotypic assays for predicting human immunodeficiency virus type 1 (HIV-1) coreceptor usage. The sensitivity of ultradeep pyrosequencing combined with genotyping tools is similar to that of phenotypic assays for detecting minor CXCR4-using variants. We evaluated the agreement between two phenotypic assays, the Toulouse tropism test (TTT) and the Trofile assay, and ultradeep pyrosequencing for determining the tropism of HIV-1 quasispecies. The concordance between the TTT and Trofile assays was assessed for 181 samples successfully phenotyped by both assays. The TTT was 86% concordant with the standard Trofile assay and 91.7% with its enhanced-sensitivity version. The concordance between phenotypic characterization of HIV-1 tropism and ultradeep pyrosequencing genotypic prediction was further studied in selected samples. The HIV-1 tropism inferred from ultradeep pyrosequencing of 11 samples phenotyped as X4 and dualtropic and 12 phenotyped as R5-tropic agreed closely with the results of phenotyping. However, ultradeep pyrosequencing detected minor CXCR4-using variants in 3 of 12 samples phenotyped as R5-tropic. Ultradeep pyrosequencing also detected minor CXCR4-using variants that had been missed by direct sequencing in 6 of 9 samples phenotyped as X4-tropic but genotyped as R5-tropic by direct sequencing. Ultradeep pyrosequencing was 87% concordant with the Trofile and TTT phenotypic assays and was in the same range of sensitivity (0.4%) than these two phenotypic assays (0.3 to 0.5%) for detecting minor CXCR4-using variants. Ultradeep pyrosequencing provides a new way to improve the performance of genotypic prediction of HIV-1 tropism to match that of the phenotypic assays.
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
Author Jacques Izopet
the ANRS AC11 Resistance Study Group
Pierre Delobel
Bernard Masquelier
Stéphanie Raymond
Adrien Saliou
Martine Dubois
Florence Nicot
Vincent Calvez
Author_xml – sequence: 1
  givenname: Adrien
  surname: SALIOU
  fullname: SALIOU, Adrien
  organization: INSERM, UMR1043, 31300,Toulouse, France
– sequence: 2
  givenname: Pierre
  surname: DELOBEL
  fullname: DELOBEL, Pierre
  organization: INSERM, UMR1043, 31300,Toulouse, France
– sequence: 3
  givenname: Martine
  surname: DUBOIS
  fullname: DUBOIS, Martine
  organization: INSERM, UMR1043, 31300,Toulouse, France
– sequence: 4
  givenname: Florence
  surname: NICOT
  fullname: NICOT, Florence
  organization: INSERM, UMR1043, 31300,Toulouse, France
– sequence: 5
  givenname: Stéphanie
  surname: RAYMOND
  fullname: RAYMOND, Stéphanie
  organization: INSERM, UMR1043, 31300,Toulouse, France
– sequence: 6
  givenname: Vincent
  surname: CALVEZ
  fullname: CALVEZ, Vincent
  organization: Laboratoire de Virologie, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, UMPC Université Paris 06, INSERM U943, Paris, France
– sequence: 7
  givenname: Bernard
  surname: MASQUELIER
  fullname: MASQUELIER, Bernard
  organization: Laboratoire de Virologie, CHU de Bordeaux, Bordeaux, France
– sequence: 8
  givenname: Jacques
  surname: IZOPET
  fullname: IZOPET, Jacques
  organization: INSERM, UMR1043, 31300,Toulouse, France
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24242470$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21464245$$D View this record in MEDLINE/PubMed
https://hal.science/hal-00675722$$DView record in HAL
BookMark eNqFktFv0zAQxi00xLrBG88oPCCERIadxI7zghR1QCdVYg8dr9bVubSeEruz01X973HWsgESQn6wzvfzd6fv7oycWGeRkNeMXjCWyU91Pb2glFYsZewZmTBayVTwSpyQCaVCpIWkxSk5C-E2UjFBX5DTjBWiyAo-Ic3UWe18A1ZjssRhh2iTxc4l12u0bthvjE7qEGAfErBNctMNHhrETXK99y7g3RatNnaVtM4nlzig740d49nVj5QlC-82JvQvyfMWuoCvjvc5ufn6ZTGdpfPv366m9TwFnldD2kpkRaGpLJccOGYNFDkFCW0GspECsRGiaAXKRlDWthXKLAeteVuJEijy_Jx8PuhutsseG402dtupjTc9-L1yYNSfGWvWauXuVc4oyyWNAh8OAuu_vs3quRrfooMlL7PsnkX2_bGYd9GGMKjeBI1dBxbdNqiKMcZlxf9PyijJSl7JSH48kDqaGzy2j00wqsZpqzht9TDtGD61C6HP1K3behvt_Rf75ndvHoV_rUIE3h0BCBq61seVMOGJK8ZTjh69PXpkVuud8ahidQWgFedKqEzmLP8J_l3L5g
CODEN AACHAX
CitedBy_id crossref_primary_10_1016_j_jviromet_2018_08_001
crossref_primary_10_1371_journal_pone_0053603
crossref_primary_10_1517_14740338_2012_640670
crossref_primary_10_1371_journal_pone_0049602
crossref_primary_10_1007_s11908_014_0401_5
crossref_primary_10_1371_journal_pone_0127816
crossref_primary_10_1016_j_jcv_2014_06_013
crossref_primary_10_1002_jmv_23209
crossref_primary_10_1093_jac_dku147
crossref_primary_10_3109_1040841X_2013_867829
crossref_primary_10_1038_srep42215
crossref_primary_10_1002_0471142727_mb0705s96
crossref_primary_10_1128_JCM_02762_14
crossref_primary_10_1038_srep16944
crossref_primary_10_1186_1742_4690_8_56
crossref_primary_10_1128_AAC_02710_13
crossref_primary_10_2217_fvl_13_21
crossref_primary_10_1016_j_dib_2015_12_008
crossref_primary_10_1093_infdis_jir719
crossref_primary_10_1093_jac_dkv026
crossref_primary_10_1097_COH_0b013e328356f6d7
crossref_primary_10_1586_14787210_2013_852469
crossref_primary_10_22207_JPAM_16_2_45
crossref_primary_10_1016_S0213_005X_11_70043_X
crossref_primary_10_1016_j_coviro_2011_09_012
crossref_primary_10_1097_QAD_0b013e3283498305
crossref_primary_10_3390_v12070758
crossref_primary_10_1371_journal_pone_0177033
crossref_primary_10_1097_COH_0b013e328356e9da
crossref_primary_10_1128_JCM_00798_13
crossref_primary_10_1128_AAC_02159_12
crossref_primary_10_1371_journal_ppat_1006754
crossref_primary_10_1093_jac_dkt290
crossref_primary_10_1016_j_antiviral_2012_11_002
crossref_primary_10_1128_JCM_00092_13
crossref_primary_10_1016_j_virusres_2016_12_008
Cites_doi 10.1016/j.jviromet.2010.06.012
10.1128/JVI.75.1.251-259.2001
10.1038/381667a0
10.1128/AAC.00853-06
10.1128/JCM.01118-06
10.1126/science.1905842
10.1177/135965350701200709
10.1086/648090
10.1016/j.jcv.2009.11.018
10.1038/nbt1371
10.1093/jac/dkq379
10.1126/science.281.5375.363
10.1038/nature03959
10.1038/34571
10.1038/381661a0
10.1126/science.272.5263.872
10.1097/QAD.0b013e32830ebcd4
10.1097/QAD.0b013e32832b4399
10.1056/NEJMoa0803154
10.1093/jac/dkp063
10.1128/AAC.49.11.4721-4732.2005
10.1056/NEJMoa0803152
10.1097/QAI.0b013e3181c8413b
10.1128/JCM.02090-06
10.1128/AAC.00148-10
10.1128/JVI.77.24.13376-13388.2003
10.1128/JCM.02439-08
10.1097/QAD.0b013e3282ef81ea
10.1086/650697
10.1128/jvi.66.5.3183-3187.1992
10.1097/QAD.0b013e32833e6cfb
10.1097/COH.0b013e328322f973
ContentType Journal Article
Contributor Montes, B
Chidiac, C
Maillard, A
Michelet, C
Weiss, L
Poizot-Martin, I
Ruffault, A
Yazdanpanah, Y
Ferré, V
Trabaud, M A
Cotte, L
Izopet, J
Raffi, F
Lazrek, M
Katlama, C
Louis, I
Neau, D
Morand-Joubert, L
Nicot, F
Cottalorda, J
Raymond, S
Verdon, R
Brun-Vezinet, F
Desbois, D
Yeni, P
Girard, P M
Pallier, C
Raymond, I
Schneider, V
Andre, P
Tamalet, C
Delobel, P
Masquelier, B
Pialoux, G
Reynes, J
Massip, P
Ravaut, I
Durant, J
Descamps, D
Morlat, P
Si-Mohammed, A
Macé, M
Flandre, F
Ragnaud, J M
Amiel, C
Recordon-Pinson, P
Tardy, J C
Dupon, M
Vittecocq, D
Dussaix, E
Soulié, C
Marcelin, A G
Fleury, H
Charpentier, C
Segondy, M
Calvez, V
Marchou, B
Vabret, A
Delfraissy, J F
Prazuck, T
Contributor_xml – sequence: 1
  givenname: P
  surname: Recordon-Pinson
  fullname: Recordon-Pinson, P
– sequence: 2
  givenname: H
  surname: Fleury
  fullname: Fleury, H
– sequence: 3
  givenname: B
  surname: Masquelier
  fullname: Masquelier, B
– sequence: 4
  givenname: A
  surname: Vabret
  fullname: Vabret, A
– sequence: 5
  givenname: C
  surname: Pallier
  fullname: Pallier, C
– sequence: 6
  givenname: M
  surname: Lazrek
  fullname: Lazrek, M
– sequence: 7
  givenname: P
  surname: Andre
  fullname: Andre, P
– sequence: 8
  givenname: J C
  surname: Tardy
  fullname: Tardy, J C
– sequence: 9
  givenname: M A
  surname: Trabaud
  fullname: Trabaud, M A
– sequence: 10
  givenname: C
  surname: Tamalet
  fullname: Tamalet, C
– sequence: 11
  givenname: B
  surname: Montes
  fullname: Montes, B
– sequence: 12
  givenname: M
  surname: Segondy
  fullname: Segondy, M
– sequence: 13
  givenname: V
  surname: Ferré
  fullname: Ferré, V
– sequence: 14
  givenname: J
  surname: Cottalorda
  fullname: Cottalorda, J
– sequence: 15
  givenname: M
  surname: Macé
  fullname: Macé, M
– sequence: 16
  givenname: D
  surname: Descamps
  fullname: Descamps, D
– sequence: 17
  givenname: F
  surname: Brun-Vezinet
  fullname: Brun-Vezinet, F
– sequence: 18
  givenname: A
  surname: Si-Mohammed
  fullname: Si-Mohammed, A
– sequence: 19
  givenname: C
  surname: Charpentier
  fullname: Charpentier, C
– sequence: 20
  givenname: D
  surname: Desbois
  fullname: Desbois, D
– sequence: 21
  givenname: E
  surname: Dussaix
  fullname: Dussaix, E
– sequence: 22
  givenname: A G
  surname: Marcelin
  fullname: Marcelin, A G
– sequence: 23
  givenname: C
  surname: Soulié
  fullname: Soulié, C
– sequence: 24
  givenname: V
  surname: Calvez
  fullname: Calvez, V
– sequence: 25
  givenname: F
  surname: Flandre
  fullname: Flandre, F
– sequence: 26
  givenname: L
  surname: Morand-Joubert
  fullname: Morand-Joubert, L
– sequence: 27
  givenname: C
  surname: Amiel
  fullname: Amiel, C
– sequence: 28
  givenname: V
  surname: Schneider
  fullname: Schneider, V
– sequence: 29
  givenname: A
  surname: Maillard
  fullname: Maillard, A
– sequence: 30
  givenname: A
  surname: Ruffault
  fullname: Ruffault, A
– sequence: 31
  givenname: J
  surname: Izopet
  fullname: Izopet, J
– sequence: 32
  givenname: F
  surname: Nicot
  fullname: Nicot, F
– sequence: 33
  givenname: P
  surname: Delobel
  fullname: Delobel, P
– sequence: 34
  givenname: S
  surname: Raymond
  fullname: Raymond, S
– sequence: 35
  givenname: P
  surname: Morlat
  fullname: Morlat, P
– sequence: 36
  givenname: I
  surname: Louis
  fullname: Louis, I
– sequence: 37
  givenname: J M
  surname: Ragnaud
  fullname: Ragnaud, J M
– sequence: 38
  givenname: D
  surname: Neau
  fullname: Neau, D
– sequence: 39
  givenname: M
  surname: Dupon
  fullname: Dupon, M
– sequence: 40
  givenname: I
  surname: Raymond
  fullname: Raymond, I
– sequence: 41
  givenname: R
  surname: Verdon
  fullname: Verdon, R
– sequence: 42
  givenname: J F
  surname: Delfraissy
  fullname: Delfraissy, J F
– sequence: 43
  givenname: Y
  surname: Yazdanpanah
  fullname: Yazdanpanah, Y
– sequence: 44
  givenname: C
  surname: Chidiac
  fullname: Chidiac, C
– sequence: 45
  givenname: L
  surname: Cotte
  fullname: Cotte, L
– sequence: 46
  givenname: I
  surname: Poizot-Martin
  fullname: Poizot-Martin, I
– sequence: 47
  givenname: I
  surname: Ravaut
  fullname: Ravaut, I
– sequence: 48
  givenname: J
  surname: Reynes
  fullname: Reynes, J
– sequence: 49
  givenname: F
  surname: Raffi
  fullname: Raffi, F
– sequence: 50
  givenname: J
  surname: Durant
  fullname: Durant, J
– sequence: 51
  givenname: T
  surname: Prazuck
  fullname: Prazuck, T
– sequence: 52
  givenname: P
  surname: Yeni
  fullname: Yeni, P
– sequence: 53
  givenname: L
  surname: Weiss
  fullname: Weiss, L
– sequence: 54
  givenname: D
  surname: Vittecocq
  fullname: Vittecocq, D
– sequence: 55
  givenname: C
  surname: Katlama
  fullname: Katlama, C
– sequence: 56
  givenname: P M
  surname: Girard
  fullname: Girard, P M
– sequence: 57
  givenname: G
  surname: Pialoux
  fullname: Pialoux, G
– sequence: 58
  givenname: C
  surname: Michelet
  fullname: Michelet, C
– sequence: 59
  givenname: B
  surname: Marchou
  fullname: Marchou, B
– sequence: 60
  givenname: P
  surname: Massip
  fullname: Massip, P
Copyright 2015 INIST-CNRS
Copyright © 2011, American Society for Microbiology
Distributed under a Creative Commons Attribution 4.0 International License
Copyright © 2011, American Society for Microbiology 2011 American Society for Microbiology
Copyright_xml – notice: 2015 INIST-CNRS
– notice: Copyright © 2011, American Society for Microbiology
– notice: Distributed under a Creative Commons Attribution 4.0 International License
– notice: Copyright © 2011, American Society for Microbiology 2011 American Society for Microbiology
CorporateAuthor ANRS AC11 Resistance Study Group
the ANRS AC11 Resistance Study Group
CorporateAuthor_xml – name: ANRS AC11 Resistance Study Group
– name: the ANRS AC11 Resistance Study Group
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7T7
7U9
8FD
C1K
FR3
H94
P64
1XC
5PM
DOI 10.1128/AAC.00091-11
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Industrial and Applied Microbiology Abstracts (Microbiology A)
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
Hyper Article en Ligne (HAL)
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
Virology and AIDS Abstracts
Technology Research Database
AIDS and Cancer Research Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList

CrossRef
MEDLINE

Virology and AIDS Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
Biology
EISSN 1098-6596
EndPage 2836
ExternalDocumentID oai_HAL_hal_00675722v1
10_1128_AAC_00091_11
0091-11
21464245
24242470
aac_55_6_2831
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
08R
0R~
23M
2WC
39C
3O-
4.4
53G
5GY
5RE
5VS
6J9
AAPBV
AAUGY
ACGFO
ADBBV
AENEX
AFMIJ
AGNAY
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1A
CS3
DIK
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HH5
HYE
HZ~
H~9
IQODW
J5H
K-O
KQ8
L7B
LSO
MVM
NEJ
O9-
OK1
P2P
RHF
RHI
RNS
RPM
RSF
TR2
UHB
VH1
W2D
W8F
WH7
WHG
WOQ
X7M
X7N
XOL
Y6R
ZA5
ZGI
ZXP
~A~
AGVNZ
CGR
CUY
CVF
ECM
EIF
NPM
-
0R
55
A
ABFLS
ADACO
BXI
HZ
AAYXX
CITATION
7X8
7T7
7U9
8FD
C1K
FR3
H94
P64
1XC
5PM
ID FETCH-LOGICAL-a539t-f8e144c087b5a5e2da430a8af2a8d86eed664f6e8d601ff9e823acc5f967a0e53
IEDL.DBID RPM
ISSN 0066-4804
IngestDate Tue Sep 17 21:20:18 EDT 2024
Tue Oct 15 15:29:50 EDT 2024
Fri Aug 16 04:19:49 EDT 2024
Wed Jul 24 13:56:37 EDT 2024
Thu Sep 12 17:51:17 EDT 2024
Tue Dec 28 13:59:10 EST 2021
Sat Sep 28 07:58:38 EDT 2024
Sun Oct 22 16:05:38 EDT 2023
Wed May 18 15:26:49 EDT 2016
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Tropism
Immunopathology
HIV-1 virus
Retroviridae
AIDS
Immune deficiency
Lentivirus
Infection
Virus
Phenotype
Viral disease
Concordance
Human immunodeficiency virus
Language English
License CC BY 4.0
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a539t-f8e144c087b5a5e2da430a8af2a8d86eed664f6e8d601ff9e823acc5f967a0e53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMCID: PMC3101380
ORCID 0000-0002-3780-5844
0000-0002-8462-3234
0000-0002-3674-1965
OpenAccessLink https://europepmc.org/articles/pmc3101380?pdf=render
PMID 21464245
PQID 875717598
PQPubID 23479
PageCount 6
ParticipantIDs crossref_primary_10_1128_AAC_00091_11
proquest_miscellaneous_911158951
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3101380
pubmed_primary_21464245
hal_primary_oai_HAL_hal_00675722v1
proquest_miscellaneous_875717598
asm2_journals_10_1128_AAC_00091_11
highwire_asm_aac_55_6_2831
pascalfrancis_primary_24242470
PublicationCentury 2000
PublicationDate 2011-06-01
PublicationDateYYYYMMDD 2011-06-01
PublicationDate_xml – month: 06
  year: 2011
  text: 2011-06-01
  day: 01
PublicationDecade 2010
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Antimicrobial Agents and Chemotherapy
PublicationTitleAbbrev Antimicrob Agents Chemother
PublicationTitleAlternate Antimicrob Agents Chemother
PublicationYear 2011
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References 20599562 - J Virol Methods. 2010 Oct;169(1):39-46
8629022 - Science. 1996 May 10;272(5263):872-7
9705713 - Science. 1998 Jul 17;281(5375):363, 365
20736814 - AIDS. 2010 Oct 23;24(16):2517-25
9440686 - Nature. 1998 Jan 15;391(6664):240
18066037 - Nat Biotechnol. 2007 Dec;25(12):1407-10
19996764 - J Acquir Immune Defic Syndr. 2010 Feb;53(2):167-75
18753930 - AIDS. 2008 Sep 12;22(14):F11-6
19439544 - J Clin Microbiol. 2009 Jul;47(7):2292-4
19339953 - Curr Opin HIV AIDS. 2009 Mar;4(2):136-42
16056220 - Nature. 2005 Sep 15;437(7057):376-80
18832245 - N Engl J Med. 2008 Oct 2;359(14):1442-55
16251317 - Antimicrob Agents Chemother. 2005 Nov;49(11):4721-32
18018768 - Antivir Ther. 2007;12(7):1097-106
11119595 - J Virol. 2001 Jan;75(1):251-9
19874179 - J Infect Dis. 2009 Dec 1;200(11):1724-8
1560543 - J Virol. 1992 May;66(5):3183-7
19424056 - AIDS. 2009 Jun 19;23(10):1209-18
14645592 - J Virol. 2003 Dec;77(24):13376-88
18832244 - N Engl J Med. 2008 Oct 2;359(14):1429-41
8649511 - Nature. 1996 Jun 20;381(6584):661-6
20947622 - J Antimicrob Chemother. 2010 Dec;65(12):2493-501
17329448 - J Clin Microbiol. 2007 May;45(5):1572-80
17721088 - AIDS. 2007 Sep 12;21(14):F17-24
8649512 - Nature. 1996 Jun 20;381(6584):667-73
17122004 - J Clin Microbiol. 2007 Feb;45(2):279-84
19261623 - J Antimicrob Chemother. 2009 May;63(5):1006-10
20530226 - Antimicrob Agents Chemother. 2010 Aug;54(8):3335-40
20151839 - J Infect Dis. 2010 Mar 15;201(6):803-13
1905842 - Science. 1991 Jul 5;253(5015):71-4
17116663 - Antimicrob Agents Chemother. 2007 Feb;51(2):566-75
20015684 - J Clin Virol. 2010 Feb;47(2):126-30
B27
McGovern, R. A. (B20) 2010; 24
Raymond, S. (B22) 2010; 47
Skrabal, K. (B31) 2007; 45
Lengauer, T., Sander, O., Sierra, S., Thielen, A., Kaiser, R. (B15) 2007; 25
Raymond, S. (B23) 2009; 47
Archer, J. (B1) 2009; 23
Cooper, D. A. (B3) 2010; 201
Lin, N. H. (B16) 2010; 169
Su, Z. (B32) 2009; 200
Feng, Y., Broder, C. C., Kennedy, P. E., Berger, E. A. (B9) 1996; 272
Gonzalez, N. (B11) 2010; 65
Rose, J. D., Rhea, A. M., Weber, J., Quinones-Mateu, M. E. (B29) 2009; 4
Raymond, S. (B25) 2010; 53
Sing, T. (B30) 2007; 12
Low, A. J. (B17) 2007; 21
Dorr, P. (B6) 2005; 49
Dragic, T. (B7) 1996; 381
Margulies, M. (B18) 2005; 437
Fouchier, R. A. (B10) 1992; 66
B19
Berger, E. A. (B2) 1998; 391
Deng, H. (B5) 1996; 381
Whitcomb, J. M. (B34) 2007; 51
Ronaghi, M., Uhlen, M., Nyren, P. (B28) 1998; 281
Hwang, S. S., Boyle, T. J., Lyerly, H. K., Cullen, B. R. (B13) 1991; 253
Jensen, M. A. (B14) 2003; 77
Trouplin, V. (B33) 2001; 75
Delobel, P. (B4) 2007; 45
Recordon-Pinson, P. (B26) 2010; 54
Poveda, E. (B21) 2009; 63
Fatkenheuer, G. (B8) 2008; 359
Gulick, R. M. (B12) 2008; 359
Raymond, S. (B24) 2008; 22
e_1_3_3_17_2
Reeves J. D. (e_1_3_3_28_2) 2007
e_1_3_3_16_2
e_1_3_3_19_2
e_1_3_3_18_2
e_1_3_3_13_2
e_1_3_3_12_2
e_1_3_3_15_2
e_1_3_3_34_2
e_1_3_3_14_2
e_1_3_3_35_2
e_1_3_3_32_2
e_1_3_3_33_2
e_1_3_3_11_2
e_1_3_3_30_2
e_1_3_3_10_2
McGovern R. (e_1_3_3_20_2) 2010
e_1_3_3_6_2
Sing T. (e_1_3_3_31_2) 2007; 12
e_1_3_3_5_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_24_2
e_1_3_3_23_2
e_1_3_3_26_2
e_1_3_3_25_2
e_1_3_3_2_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_3_2
e_1_3_3_21_2
References_xml – volume: 47
  start-page: 126
  year: 2010
  end-page: 130
  ident: B22
  article-title: Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage
  publication-title: J. Clin. Virol
  contributor:
    fullname: Raymond, S.
– ident: B19
  article-title: McGovern R. . 2010 . Population-based sequencing of the V3-loop is comparable to the enhanced sensitivity Trofile assay in predicting virologic response to maraviroc of treatment-naive patients in the MERIT Trial . 17th Conference on Retroviruses and Opportunistic Infections , San Francisco, CA .
– volume: 63
  start-page: 1006
  year: 2009
  end-page: 1010
  ident: B21
  article-title: Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists
  publication-title: J. Antimicrob. Chemother
  contributor:
    fullname: Poveda, E.
– volume: 272
  start-page: 872
  year: 1996
  end-page: 877
  ident: B9
  article-title: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
  publication-title: Science
  contributor:
    fullname: Berger, E. A.
– volume: 169
  start-page: 39
  year: 2010
  end-page: 46
  ident: B16
  article-title: The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates
  publication-title: J. Virol. Methods
  contributor:
    fullname: Lin, N. H.
– ident: B27
  article-title: Reeves J. D. . 2007 . Enhancements to the Trofile HIV coreceptor tropism assay enable reliable detection of CXCR4-using subpopulations at <1% . 47th Annu. Intersci. Conf. Antimicrob. Agents Chemother .
– volume: 22
  start-page: F11
  year: 2008
  end-page: F16
  ident: B24
  article-title: Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism
  publication-title: AIDS
  contributor:
    fullname: Raymond, S.
– volume: 201
  start-page: 803
  year: 2010
  end-page: 813
  ident: B3
  article-title: Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection
  publication-title: J. Infect. Dis
  contributor:
    fullname: Cooper, D. A.
– volume: 24
  start-page: 2517
  year: 2010
  end-page: 2525
  ident: B20
  article-title: Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies
  publication-title: AIDS
  contributor:
    fullname: McGovern, R. A.
– volume: 54
  start-page: 3335
  year: 2010
  end-page: 3340
  ident: B26
  article-title: Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study
  publication-title: Antimicrob. Agents Chemother
  contributor:
    fullname: Recordon-Pinson, P.
– volume: 391
  start-page: 240
  year: 1998
  ident: B2
  article-title: A new classification for HIV-1
  publication-title: Nature
  contributor:
    fullname: Berger, E. A.
– volume: 253
  start-page: 71
  year: 1991
  end-page: 74
  ident: B13
  article-title: Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
  publication-title: Science
  contributor:
    fullname: Cullen, B. R.
– volume: 65
  start-page: 2493
  year: 2010
  end-page: 2501
  ident: B11
  article-title: A sensitive phenotypic assay for the determination of human immunodeficiency virus type 1 tropism
  publication-title: J. Antimicrob. Chemother
  contributor:
    fullname: Gonzalez, N.
– volume: 21
  start-page: F17
  year: 2007
  end-page: F24
  ident: B17
  article-title: Current V3 genotyping algorithms are inadequate for predicting X4 coreceptor usage in clinical isolates
  publication-title: AIDS
  contributor:
    fullname: Low, A. J.
– volume: 49
  start-page: 4721
  year: 2005
  end-page: 4732
  ident: B6
  article-title: Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity
  publication-title: Antimicrob. Agents Chemother
  contributor:
    fullname: Dorr, P.
– volume: 4
  start-page: 136
  year: 2009
  end-page: 142
  ident: B29
  article-title: Current tests to evaluate HIV-1 coreceptor tropism
  publication-title: Curr. Opin. HIV AIDS
  contributor:
    fullname: Quinones-Mateu, M. E.
– volume: 437
  start-page: 376
  year: 2005
  end-page: 380
  ident: B18
  article-title: Genome sequencing in microfabricated high-density picolitre reactors
  publication-title: Nature
  contributor:
    fullname: Margulies, M.
– volume: 51
  start-page: 566
  year: 2007
  end-page: 575
  ident: B34
  article-title: Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism
  publication-title: Antimicrob. Agents Chemother
  contributor:
    fullname: Whitcomb, J. M.
– volume: 77
  start-page: 13376
  year: 2003
  end-page: 13388
  ident: B14
  article-title: Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences
  publication-title: J. Virol
  contributor:
    fullname: Jensen, M. A.
– volume: 381
  start-page: 661
  year: 1996
  end-page: 666
  ident: B5
  article-title: Identification of a major coreceptor for primary isolates of HIV-1
  publication-title: Nature
  contributor:
    fullname: Deng, H.
– volume: 66
  start-page: 3183
  year: 1992
  end-page: 3187
  ident: B10
  article-title: Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule
  publication-title: J. Virol
  contributor:
    fullname: Fouchier, R. A.
– volume: 381
  start-page: 667
  year: 1996
  end-page: 673
  ident: B7
  article-title: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
  publication-title: Nature
  contributor:
    fullname: Dragic, T.
– volume: 23
  start-page: 1209
  year: 2009
  end-page: 1218
  ident: B1
  article-title: Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing
  publication-title: AIDS
  contributor:
    fullname: Archer, J.
– volume: 359
  start-page: 1429
  year: 2008
  end-page: 1441
  ident: B12
  article-title: Maraviroc for previously treated patients with R5 HIV-1 infection
  publication-title: N. Engl. J. Med
  contributor:
    fullname: Gulick, R. M.
– volume: 281
  start-page: 363
  year: 1998
  end-page: 365
  ident: B28
  article-title: A sequencing method based on real-time pyrophosphate
  publication-title: Science
  contributor:
    fullname: Nyren, P.
– volume: 75
  start-page: 251
  year: 2001
  end-page: 259
  ident: B33
  article-title: Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay
  publication-title: J. Virol
  contributor:
    fullname: Trouplin, V.
– volume: 12
  start-page: 1097
  year: 2007
  end-page: 1106
  ident: B30
  article-title: Predicting HIV coreceptor usage on the basis of genetic and clinical covariates
  publication-title: Antivir. Ther
  contributor:
    fullname: Sing, T.
– volume: 200
  start-page: 1724
  year: 2009
  end-page: 1728
  ident: B32
  article-title: Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211
  publication-title: J. Infect. Dis
  contributor:
    fullname: Su, Z.
– volume: 47
  start-page: 2292
  year: 2009
  end-page: 2294
  ident: B23
  article-title: Genotypic prediction of human immunodeficiency virus type 1 CRF02-AG tropism
  publication-title: J. Clin. Microbiol
  contributor:
    fullname: Raymond, S.
– volume: 53
  start-page: 167
  year: 2010
  end-page: 175
  ident: B25
  article-title: Prediction of HIV type 1 subtype C tropism by genotypic algorithms built from subtype B viruses
  publication-title: J. Acquir. Immune Defic. Syndr
  contributor:
    fullname: Raymond, S.
– volume: 45
  start-page: 279
  year: 2007
  end-page: 284
  ident: B31
  article-title: Determining human immunodeficiency virus coreceptor use in a clinical setting: degree of correlation between two phenotypic assays and a bioinformatic model
  publication-title: J. Clin. Microbiol
  contributor:
    fullname: Skrabal, K.
– volume: 25
  start-page: 1407
  year: 2007
  end-page: 1410
  ident: B15
  article-title: Bioinformatics prediction of HIV coreceptor usage
  publication-title: Nat. Biotechnol
  contributor:
    fullname: Kaiser, R.
– volume: 45
  start-page: 1572
  year: 2007
  end-page: 1580
  ident: B4
  article-title: Population-based sequencing of the V3 region of env for predicting the coreceptor usage of human immunodeficiency virus type 1 quasispecies
  publication-title: J. Clin. Microbiol
  contributor:
    fullname: Delobel, P.
– volume: 359
  start-page: 1442
  year: 2008
  end-page: 1455
  ident: B8
  article-title: Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection
  publication-title: N. Engl. J. Med
  contributor:
    fullname: Fatkenheuer, G.
– ident: e_1_3_3_17_2
  doi: 10.1016/j.jviromet.2010.06.012
– ident: e_1_3_3_34_2
  doi: 10.1128/JVI.75.1.251-259.2001
– ident: e_1_3_3_8_2
  doi: 10.1038/381667a0
– ident: e_1_3_3_35_2
  doi: 10.1128/AAC.00853-06
– ident: e_1_3_3_32_2
  doi: 10.1128/JCM.01118-06
– ident: e_1_3_3_14_2
  doi: 10.1126/science.1905842
– volume: 12
  start-page: 1097
  year: 2007
  ident: e_1_3_3_31_2
  article-title: Predicting HIV coreceptor usage on the basis of genetic and clinical covariates
  publication-title: Antivir. Ther
  doi: 10.1177/135965350701200709
  contributor:
    fullname: Sing T.
– ident: e_1_3_3_33_2
  doi: 10.1086/648090
– ident: e_1_3_3_23_2
  doi: 10.1016/j.jcv.2009.11.018
– ident: e_1_3_3_16_2
  doi: 10.1038/nbt1371
– ident: e_1_3_3_12_2
  doi: 10.1093/jac/dkq379
– ident: e_1_3_3_29_2
  doi: 10.1126/science.281.5375.363
– ident: e_1_3_3_19_2
  doi: 10.1038/nature03959
– ident: e_1_3_3_3_2
  doi: 10.1038/34571
– ident: e_1_3_3_6_2
  doi: 10.1038/381661a0
– ident: e_1_3_3_10_2
  doi: 10.1126/science.272.5263.872
– ident: e_1_3_3_25_2
  doi: 10.1097/QAD.0b013e32830ebcd4
– ident: e_1_3_3_2_2
  doi: 10.1097/QAD.0b013e32832b4399
– volume-title: 17th Conference on Retroviruses and Opportunistic Infections
  year: 2010
  ident: e_1_3_3_20_2
  contributor:
    fullname: McGovern R.
– ident: e_1_3_3_9_2
  doi: 10.1056/NEJMoa0803154
– ident: e_1_3_3_22_2
  doi: 10.1093/jac/dkp063
– ident: e_1_3_3_7_2
  doi: 10.1128/AAC.49.11.4721-4732.2005
– ident: e_1_3_3_13_2
  doi: 10.1056/NEJMoa0803152
– ident: e_1_3_3_26_2
  doi: 10.1097/QAI.0b013e3181c8413b
– volume-title: 47th Annu. Intersci. Conf. Antimicrob. Agents Chemother
  year: 2007
  ident: e_1_3_3_28_2
  contributor:
    fullname: Reeves J. D.
– ident: e_1_3_3_5_2
  doi: 10.1128/JCM.02090-06
– ident: e_1_3_3_27_2
  doi: 10.1128/AAC.00148-10
– ident: e_1_3_3_15_2
  doi: 10.1128/JVI.77.24.13376-13388.2003
– ident: e_1_3_3_24_2
  doi: 10.1128/JCM.02439-08
– ident: e_1_3_3_18_2
  doi: 10.1097/QAD.0b013e3282ef81ea
– ident: e_1_3_3_4_2
  doi: 10.1086/650697
– ident: e_1_3_3_11_2
  doi: 10.1128/jvi.66.5.3183-3187.1992
– ident: e_1_3_3_21_2
  doi: 10.1097/QAD.0b013e32833e6cfb
– ident: e_1_3_3_30_2
  doi: 10.1097/COH.0b013e328322f973
SSID ssj0006590
Score 2.2985876
Snippet Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
There have been few studies on the concordance between phenotypic assays for predicting human immunodeficiency virus type 1 (HIV-1) coreceptor usage. The...
ABSTRACT There have been few studies on the concordance between phenotypic assays for predicting human immunodeficiency virus type 1 (HIV-1) coreceptor usage....
SourceID pubmedcentral
hal
proquest
crossref
asm2
pubmed
pascalfrancis
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 2831
SubjectTerms Adult
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral Agents
Biological and medical sciences
CCR5 Receptor Antagonists
Genotyping
HIV-1
HIV-1 - genetics
HIV-1 - physiology
Human immunodeficiency virus 1
Human viral diseases
Humans
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunopathology
Infectious diseases
Life Sciences
Medical sciences
Microbiology and Parasitology
Middle Aged
Pharmacology. Drug treatments
Phenotype
Phenotyping
Receptors, CCR5
Receptors, CXCR4
Receptors, CXCR4 - physiology
Sequence Analysis, DNA
Tropism
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Viral Tropism
Title Concordance between Two Phenotypic Assays and Ultradeep Pyrosequencing for Determining HIV-1 Tropism
URI http://aac.asm.org/content/55/6/2831.abstract
https://www.ncbi.nlm.nih.gov/pubmed/21464245
https://journals.asm.org/doi/10.1128/AAC.00091-11
https://search.proquest.com/docview/875717598
https://search.proquest.com/docview/911158951
https://hal.science/hal-00675722
https://pubmed.ncbi.nlm.nih.gov/PMC3101380
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfWSSBeEJSvblBZE-xpWZP4I85jVZgKoqgPLdqb5TiOVmlNqqUD5b_fXT5aitgLj0kuTpy7y53t3_1MyEdpY0haBfMcs77HRcS9BAt8eBAgPxwLpMVq5NkPOV3yb9fi-oiIrhamBu3bZHWZ364v89VNja3crO2ow4mN5rMJpCQBU_6oR3oRY90Qvf39StFMrEAs9bjyeYd2D9VoPJ4gX2EceEFQswBziQt_8Dc25To8iEy9G8RF7jiDETJpSvhqWbPdxb_y0b9hlX_EqasX5HmbYNJx05GX5MjlffKk2XKy6pOns3YxvU_O5w1tdXVBF_sqrPKCntP5ntC6ekXSSYFslykaCG2BXXTxuwAxlxfbarOyFNRsqpKaPKXLW3iv1LkNnVfQ0warDRGSQn5MP7fwGzyefv3pBXRxV2xW5fo1WV59WUymXrs7g2cEi7dephwMxqyvokQY4cLUcOYbZbLQqFRJiL1S8kw6lcKYL8tip0JmrBVZLCPjO8HekOO8yN07QpWKM65k4oRMeZbGCfLyqdCyVIApSTUgZ6gg3bpXqeuRS6g0KFTXCoXDAfnUqU9vGqaOR-TOQLc7EaTXno6_azyHoVtEYfgLhE461Wt4tDbGaiG01JCNwcXhgTHs2sJSm5BH_oDQzjo0eCsuwZjcFfelxu0DIGGL1eMiGH2EgsR3QN429rRvvzXYAYkOLO2gM4dXwIVqzvDWZU7--85T8qyZTscJqPfkeHt37z5APrZNhhgNxbD2wgc5iDFn
link.rule.ids 230,315,733,786,790,891,27955,27956,53825,53827
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwGLW2IWAXfpTBOmBYE-y0tIljO86xKkwdtFMP7bSb5TiOVrEm1dKCwl_P5_xo6cQOcEz9NZXdZ3_P9vMzQh-5DoG0Mt8xvnYdygLqRPaAD_U86w_ne1zb08ijSz6Y0q_X7HoHseYsTCna19Gsk97OO-nsptRWLua62-jEuuNRHyiJ5wu3u4seQX8lrJmk1wMwZ9XSCmRThwqXNnp3Irq9Xt86Foae43mlDzDldusPxmOVz8lWbtq9scrItWuwFU2qHNotqS68-BsjvS-s_CNTnT9HV00dK4HK985qGXX0r3v2j__cCC_Qs5q74l5V_BLtmLSFHle3WRYt9GRU79O30Om4csQuzvBkc8ArP8OneLzxyi5eobifWSPN2GIP15oxPPmZQZhJs2WxmGkMCFJFjlUa4-ktVDg2ZoHHBTRhJQOH5IuBeuPPtbLHPg8urhwPT-6yxSyfH6Dp-ZdJf-DUFz84ivnh0kmEgXmedkUQMcUMiRX1XSVUQpSIBYe0zjlNuBExTCeTJDSC-EprloQ8UK5h_mu0l2apOURYiDChgkeG8ZgmcRhZyz9BtB8zQCkXbXRi_3lZ99xclpMiIiQgRZZIgcc2-tTgQi4qE5AH4k4ANOsQ69w96A2l_cyyAhYQ8gOCjhpMSfhpqZSWjEkugehB4fEWytbvsqd4CA3cNsIN7CQMBHZ3R6UmW-XS3kwAXDAUD4fYxMYEcOo2elMBdfP-uie0UbAF4a3KbJcAMEs78hqIR__9zQ_o6WAyGsrhxeW3t2i_WrW361zv0N7ybmXeA-1bRsdlJ_8NdSlSZw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwGLXYEBMvXMqtA4Y1wZ6WNhfbcR6rjqqDdepDhyZeLMd2tIo1iZYWFH49n3Np14m97DHJ10R2j_0d28fHCH1mKgLSSgPHBMp1CA2JE9sNPsTzrD9c4DFldyNPztn4gny7pJe3jvqqRPsqnvfS60UvnV9V2sp8ofqtTqw_nQyBkngBd_u5Tvo76DG0WT9sB-pNJ8xoPb0CGdUh3CWt5t3n_cFgaF0LI8_xvMoLmDC7_Ad9siwW_lZ-2rmy6si1c7AVTsoC6i6pD734Hyu9K668la1Gz9HPtpy1SOVXb7WMe-rvHQvIB1XEC_Ss4bB4UIe8RI9M2kFP6lMtyw7amzTr9R10NK2dsctjPNts9CqO8RGebjyzy1dIDzNrqKktBnGjHcOzPxmEmTRblvlcYUCSLAssU40vrqHQ2pgcT0uoxloODkkYAwXHJ43Cx16PT384Hp7dZPm8WLxGF6Ovs-HYaQ6AcCQNoqWTcAPjPeXyMKaSGl9LEriSy8SXXHMG6Z0xkjDDNQwrkyQy3A-kUjSJWChdQ4M3aDfNUvMOYc6jhHAWG8o0SXQUW-s_7qtAU0Ar4110aP990bTgQlSDI58LQIuo0AKXXfSlxYbIazOQe-IOATjrEOvgPR6cCXvPsgMa-v5vCNpvcSXg00JKJSgVTADhg4cHW0hbv8vu5vFJ6HYRbqEnoEOwqzwyNdmqEPaEAuCEEb8_xCY4yoFbd9HbGqyb9zetoYvCLRhvFWb7CYCzsiVvwLj_4F9-QnvTk5E4Oz3__h49rSfv7XTXB7S7vFmZj8D-lvFB1c7_AQegVOc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Concordance+between+two+phenotypic+assays+and+ultradeep+pyrosequencing+for+determining+HIV-1+tropism&rft.jtitle=Antimicrobial+agents+and+chemotherapy&rft.au=Saliou%2C+Adrien&rft.au=Delobel%2C+Pierre&rft.au=Dubois%2C+Martine&rft.au=Nicot%2C+Florence&rft.date=2011-06-01&rft.eissn=1098-6596&rft.volume=55&rft.issue=6&rft.spage=2831&rft.epage=2836&rft_id=info:doi/10.1128%2FAAC.00091-11&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0066-4804&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0066-4804&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0066-4804&client=summon